First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Condition(s):Advanced Malignant Neoplasm; Acute Myeloid Leukemia; Mixed Lineage Leukemia; Mixed Lineage Acute Leukemia; Acute Leukemia of Ambiguous Lineage; Mixed Phenotype Acute LeukemiaLast Updated:March 15, 2024Recruiting